Identification and Targeting of Long-Term Tumor-Propagating Cells in Small Cell Lung Cancer

Area of Science:

• Oncology
• Cancer Biology
• Molecular Therapeutics

Background:

• Small cell lung cancer (SCLC) is an aggressive neuroendocrine lung cancer known for rapid progression and treatment resistance.
• Tumor-propagating cells (TPCs) are crucial for tumor growth and recurrence, but their role in SCLC is not fully understood.

Purpose of the Study:

• To identify and characterize a population of long-term tumor-propagating cells (TPCs) in small cell lung cancer (SCLC).
• To investigate the molecular mechanisms, including MYC activity, driving SCLC TPC function.
• To explore therapeutic strategies targeting SCLC TPCs.

Main Methods:

• Utilized a mouse model of SCLC to isolate and study tumor-propagating cells (TPCs).
• Analyzed cell surface markers (EpCAM, CD24) and transcriptional profiles of SCLC TPCs.
• Employed genetic and pharmacological inhibition of MYC to assess its role in TPC propagation.

Main Results:

• Identified a distinct population of EpCAM and CD24 high SCLC TPCs in mouse models and human tumors.
• SCLC TPCs exhibit a unique transcriptional profile with elevated MYC activity.
• Inhibition of MYC reduced long-term tumor propagation in SCLC cells, but not short-term growth.

Conclusions:

• A highly tumorigenic SCLC TPC population exists and is conserved across species.
• MYC activity is critical for the long-term propagation of SCLC TPCs.
• Targeting MYC presents a potential therapeutic avenue for treating SCLC by inhibiting TPC function.